Showing results (271-280 of 300) with videos related to
Sort By:
Pageof 30
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 18, 2008
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patientsAlessio G Morganti, Savino Cilla, Vincenzo Valentini, et al.Gynecologic Oncology|January 26, 2024
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO groupLucia Musacchio, Eleonora Palluzzi, Marilena Di Napoli, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2026
Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancerSavino Cilla, Francesco Deodato, Donato Pezzulla, et al.La Radiologia Medica|September 12, 2023
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)Gabriella Macchia, Valentina Lancellotta, Martina Ferioli, et al.Gynecologic Oncology|October 9, 2016
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)Claudia Marchetti, Gabriella Ferrandina, Gennaro Cormio, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2024
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 studyValentina Tuninetti, Elisa Virano, Vanda Salutari, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2023
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional studySavino Cilla, Maura Campitelli, Maria Antonietta Gambacorta, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 23, 2022
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groupsGabriella Macchia, Alessia Nardangeli, Concetta Laliscia, et al.International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group GroupsGabriella Macchia, Donato Pezzulla, Maura Campitelli, et al.Gynecologic Oncology|December 21, 2016
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trialGennaro Daniele, Domenica Lorusso, Giovanni Scambia, et al.Pageof 30